Qiming Medical -B (Stock Code: 2500) will hold its 2023 annual general meeting of shareholders in Hangzhou, China on June 28, 2024 at 2 pm. The meeting will review agendas including annual reports, board of directors and supervisory board work reports, profit distribution plans, and reappointment of auditors. Relevant documents of the general meeting of shareholders will be released on June 7, 2024. H share transfer registration will be suspended from June 25-28 and shareholders are required to complete relevant procedures for attending and voting in the meeting. Mr. Lin Haosheng, Executive Director of the company, issued a notice on June 7, 2024.

Qiming Medical -B (Stock Code: 2500) will hold its 2023 annual general meeting of shareholders in Hangzhou, China on June 28, 2024 at 2 pm. The meeting will review agendas including annual reports, board of directors and supervisory board work reports, profit distribution plans, and reappointment of auditors. Relevant documents of the general meeting of shareholders will be released on June 7, 2024. H share transfer registration will be suspended from June 25-28 and shareholders are required to complete relevant procedures for attending and voting in the meeting. Mr. Lin Haosheng, Executive Director of the company, issued a notice on June 7, 2024.